Tamaki Hiroyuki, Eriguchi Masahiro, Yoshida Hisako, Uemura Takayuki, Tasaki Hikari, Nishimoto Masatoshi, Kosugi Takaaki, Samejima Ken-Ichi, Iseki Kunitoshi, Fujimoto Shouichi, Konta Tsuneo, Moriyama Toshiki, Yamagata Kunihiro, Narita Ichiei, Kasahara Masato, Shibagaki Yugo, Kondo Masahide, Asahi Koichi, Watanabe Tsuyoshi, Tsuruya Kazuhiko
Department of Nephrology, Nara Medical University, Kashihara, Nara, Japan.
Department of Medical Statistics, Osaka Metropolitan University Graduate School of Medicine, Osaka, Osaka, Japan.
Clin Kidney J. 2024 May 25;17(6):sfae152. doi: 10.1093/ckj/sfae152. eCollection 2024 Jun.
Unlike systolic blood pressure (SBP), the prognostic value of diastolic blood pressure (DBP) in kidney function has not been established. We hypothesized that pulse pressure (PP), which is associated with arteriosclerosis, would affect the prognostic value of DBP.
This longitudinal study used data from the Japan Specific Health Checkups Study was conducted between 2008 and 2014. The participants were stratified into three PP subgroups (low PP ≤39, normal PP 40-59 and high PP ≥60 mmHg). The exposures of interest were SBP and DBP, and the association between SBP/DBP and kidney outcomes (30% decline in the estimated glomerular filtration rate from baseline) was examined in each PP subgroup using a Cox proportional hazards model.
Among 725 022 participants, 20 414 (2.8%) developed kidney outcomes during a median follow-up period of 34.6 months. Higher SBP was consistently associated with a higher incidence of kidney outcome in all PP subgroups. Although DBP had a positive linear association with the incidence of kidney outcome in low- and normal-PP subgroups, both lower (≤60 mmHg) and higher (≥101 mmHg) DBP were associated with a higher incidence of kidney outcome in the high-PP subgroup, with a U-shaped curve. Hazard ratios (95% confidence intervals) of ≤60 mmHg (reference: 61-80 mmHg in normal-PP subgroup) and ≥101 mmHg were 1.26 (1.15-1.38) and 1.86 (1.62-2.14), respectively.
In this large population-based cohort, DBP was differently associated with kidney outcome by PP level; lower DBP was significantly associated with a higher incidence of kidney outcome in the high-PP subgroup but not in the low- and normal-PP subgroups.
与收缩压(SBP)不同,舒张压(DBP)对肾功能的预后价值尚未明确。我们推测,与动脉硬化相关的脉压(PP)会影响DBP的预后价值。
这项纵向研究使用了2008年至2014年期间日本特定健康检查研究的数据。参与者被分为三个PP亚组(低PP≤39、正常PP 40 - 59和高PP≥60 mmHg)。感兴趣的暴露因素为SBP和DBP,并使用Cox比例风险模型在每个PP亚组中检查SBP/DBP与肾脏结局(估计肾小球滤过率较基线下降30%)之间的关联。
在725022名参与者中,在中位随访期34.6个月期间,有20414名(2.8%)出现了肾脏结局。在所有PP亚组中,较高的SBP始终与较高的肾脏结局发生率相关。虽然DBP在低PP和正常PP亚组中与肾脏结局发生率呈正线性关联,但在高PP亚组中,较低(≤60 mmHg)和较高(≥101 mmHg)的DBP均与较高的肾脏结局发生率相关,呈U形曲线。≤60 mmHg(参考:正常PP亚组中的61 - 80 mmHg)和≥101 mmHg的风险比(95%置信区间)分别为1.26(1.15 - 1.38)和1.86(1.62 - 2.14)。
在这个基于人群的大型队列中,DBP与肾脏结局的关联因PP水平而异;在高PP亚组中,较低的DBP与较高的肾脏结局发生率显著相关,而在低PP和正常PP亚组中并非如此。